BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 4038918)

  • 1. Sequence-dependent synergism between dichloromethotrexate and cisplatin in a human colon carcinoma cell line.
    Sobrero AF; Bertino JR
    Cancer Treat Rep; 1985 Mar; 69(3):279-83. PubMed ID: 4038918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequence-dependent synergism between dichloromethotrexate and 5-fluorouracil in a human colon carcinoma cell line.
    Sobrero AF; Bertino JR
    Cancer Res; 1983 Sep; 43(9):4011-13. PubMed ID: 6871843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clonogenic patterns of human pulmonary adenocarcinoma cell lines (PC-9, PC-13 and PC-14) and how they influence the results of test for chemosensitivity to cisplatin in the human tumor clonogenic assay.
    Lee YC; Saijo N; Sasaki Y; Takahashi H; Sakurai M; Ishihara J; Hoshi A; Chen KM; Hamburger AW
    Jpn J Clin Oncol; 1985 Dec; 15(4):637-44. PubMed ID: 4094096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro synergism between 5-fluorouracil and natural beta interferon in human colon carcinoma cells.
    Guglielmi A; Aschele C; Mori A; Baldo C; Russo P; Debernardis D; Valenti M; Bruno S; Taverna M; Rosso R
    Clin Cancer Res; 1995 Nov; 1(11):1337-44. PubMed ID: 9815929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of synergy between cisplatin and cytarabine against ovarian carcinoma in vitro.
    Howell SB; Gill S
    Cancer Treat Rep; 1986 Mar; 70(3):409-10. PubMed ID: 3955553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of in vitro drug sensitivity by inhibition of tritium release from [5-3H]-2'-deoxyuridine and a clonogenic assay.
    Aschele C; Romanini A; Nicolin A; Rosso R; Sobrero A
    Anticancer Res; 1990; 10(3):759-64. PubMed ID: 2195987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential sensitivities of human testicular and bladder tumor cell lines to chemotherapeutic drugs.
    Walker MC; Parris CN; Masters JR
    J Natl Cancer Inst; 1987 Aug; 79(2):213-6. PubMed ID: 3474453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro test-system for chemo- and thermosensitivity: an analysis of survival fractions and cell-cycle distributions in human Ewing's sarcomas as a modelfor tumors in pediatric oncology.
    Debes A; Rommel F; Breise M; Willers R; Göbel U; Wessalowski R
    Klin Padiatr; 2002; 214(4):223-9. PubMed ID: 12165906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endogenous thymidine and hypoxanthine are a source of error in evaluating methotrexate cytotoxicity by clonogenic assays using undialyzed fetal bovine serum.
    Sobrero AF; Bertino JR
    Int J Cell Cloning; 1986 Jan; 4(1):51-62. PubMed ID: 2936838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination chemotherapy in vitro. IV. Response of human colon carcinoma cells to combinations using cis-diamminedichloroplatinum.
    Bergerat JP; Green C; Drewinko B
    Cancer Biochem Biophys; 1979; 3(4):173-80. PubMed ID: 575983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of recombinant methioninase in combination with cisplatin on human colon tumors in nude mice.
    Tan Y; Sun X; Xu M; Tan X; Sasson A; Rashidi B; Han Q; Tan X; Wang X; An Z; Sun FX; Hoffman RM
    Clin Cancer Res; 1999 Aug; 5(8):2157-63. PubMed ID: 10473100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular basis for the inefficacy of 5-FU in human colon carcinoma.
    Drewinko B; Yang LY
    Cancer Treat Rep; 1985 Dec; 69(12):1391-8. PubMed ID: 4075316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A bioassay of cisplatin by human tumor clonogenic assay.
    Sasaki Y; Saijo N; Lee YC; Takahashi H; Ishihara J; Sakurai M; Sano T; Nakano H; Kanzawa F; Hoshi A
    Jpn J Cancer Res; 1986 May; 77(5):494-501. PubMed ID: 3089981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of cis-dichlorodiammineplatinum(II) on human colon carcinoma cells in vitro.
    Bergerat JP; Barlogie B; Drewinko B
    Cancer Res; 1979 Apr; 39(4):1334-8. PubMed ID: 421217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of dexamethasone effect on the antitumor activity of cisplatin.
    Aapro MS; Alberts DS; Serokman R
    Cancer Treat Rep; 1983 Nov; 67(11):1013-7. PubMed ID: 6685569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Analysis of drug sensitivity by successive colony-forming assay].
    Azuma A; Hino M; Hirosawa A; Shimabukuro Z; Aoyama A; Ootsuka M; Matsusaka M; Niitani H
    Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 2):815-20. PubMed ID: 3032106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined gamma-irradiation and subsequent cisplatin treatment in human squamous carcinoma cell lines sensitive and resistant to cisplatin.
    Caney C; Singh G; Lukka H; Rainbow AJ
    Int J Radiat Biol; 2004 Apr; 80(4):291-9. PubMed ID: 15204706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sub-additive effect of the combination of radiation and cisplatin in cultured murine and human cell lines.
    Gorodetsky R; Mou X; Pfeffer MR; Peretz T; Levy-Agababa F; Vexler AM
    Isr J Med Sci; 1995; 31(2-3):95-100. PubMed ID: 7744601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Schedule-dependent synergism and antagonism between paclitaxel and methotrexate in human carcinoma cell lines.
    Kano Y; Akutsu M; Tsunoda S; Furuta M; Yazawa Y; Ando J
    Oncol Res; 1998; 10(7):347-54. PubMed ID: 10063968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potentiation of cisplatin antitumor activity using a vitamin D analogue in a murine squamous cell carcinoma model system.
    Light BW; Yu WD; McElwain MC; Russell DM; Trump DL; Johnson CS
    Cancer Res; 1997 Sep; 57(17):3759-64. PubMed ID: 9288784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.